NCT00655733View on ClinicalTrials.gov

Phase II Study of HMPL-004 in Subjects With Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Crohn's Disease
Interventions
DRUG

HMPL-004

HMPL-004 1200 mg/d

DRUG

Placebo

Placebo 1200 mg/d

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT00655733 - Phase II Study of HMPL-004 in Subjects With Crohn's Disease | Biotech Hunter | Biotech Hunter